HIGHLIGHTS
- who: Shanshan Hou and colleagues from the Department of Pharmacy, Zhejiang Pharmaceutical College, Ningbo, China, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Henan Province Engineering Research Center of Artificial Intelligence and Internet of Things have published the paper: Application Perspectives of Nanomedicine in Cancer Treatment, in the Journal: (JOURNAL)
- how: Lo et_al conjugated doxorubicin to the ApoB protein of LDL and the results showed that it significantly reduced the occurrence of adverse reactions.
SUMMARY
Replacing traditional drug delivery with NDSs can enhance the efficacy of treatment and reduce . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.